Many patients report improvements in physical functioning and reduced joint pain with weight loss
That might not sound catastrophic, but when you are on a carefully calibrated dosing protocol , a 10 percent reduction means your 0.5 mg dose is really delivering 0.45 mg
The result at week 68: Continued semaglutide 2.4 mg: lost an additional 7.9% of body weight (total loss from baseline: 17.4%) Switched to placebo: regained 6.9% of body weight (net loss from baseline: 5.0%) Thats a roughly 15-point difference in body weight between the two groups at the end of the trial, attributable entirely to whether the medication continued
Wearing supportive footwear and avoiding long periods in the same position Some people use supplements, such as magnesium, to reduce muscle cramps
You should also report ongoing vomiting, signs of dehydration, or intense abdominal pain
One study from May in the European Journal of Clinical Pharmacology found that patients on retatrutide were more likely to report dysesthesia, which is the medical term for strange sensations on your skin